Legal & General Group PLC Chemo Centryx, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

Shares

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $81,585 - $190,624	3,680 Added 7.22%	54,674 $2.83 Million
Q2 2022 Aug 22, 2022	BUY	$15.36 - $27.51 $124,584 - $223,133	8,111 Added 18.91%	50,994 $1.26 Million
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $5,799 - $10,210	261 Added 0.61%	42,883 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $1,617 - $3,564	-88 Reduced 0.21%	42,622 $1.55 Million
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $126,198 - $189,872	9,575 Added 28.9%	42,710 $731,000
Q2 2021 Aug 12, 2021	SELL	$9.59 - $50.88 $10,338 - $54,848	-1,078 Reduced 3.15%	33,135 $443,000
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $17,929 - $24,760	-362 Reduced 1.05%	34,213 $1.75 Million
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $2,882 - $3,974	-61 Reduced 0.18%	34,575 $2.14 Million
Q3 2020 Nov 13, 2020	BUY	$46.35 - $61.69 $316,709 - $421,527	6,833 Added 24.58%	34,636 $1.9 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $29,320 - $49,453	760 Added 2.81%	27,803 $1.6 Million
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $559,093 - $867,423	17,082 Added 171.49%	27,043 $1.09 Million
Q4 2019 Feb 13, 2020	BUY	$6.81 - $39.55 $10,916 - $63,398	1,603 Added 19.18%	9,961 $394,000
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $26,384 - $47,148	3,175 Added 61.26%	8,358 $78,000
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $15,695 - $21,779	1,568 Added 43.37%	5,183 $72,000
Q4 2018 Feb 15, 2019	BUY	$9.15 - $12.26 $5,435 - $7,282	594 Added 19.66%	3,615 $39,000
Q2 2018 Aug 10, 2018	SELL	$10.62 - $13.98 $16,588 - $21,836	-1,562 Reduced 34.08%	3,021 $40,000
Q1 2018 May 17, 2018	SELL	$5.9 - $14.99 $3,127 - $7,944	-530 Reduced 10.37%	4,583 $62,000
Q4 2017 Feb 13, 2018	BUY	$5.53 - $8.42 $28,274 - $43,051	5,113	5,113 $30,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.